BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35810355)

  • 1. Inflammasome activation in preeclampsia and intrauterine growth restriction.
    Silber M; Dekel N; Heusler I; Biron-Shental T; Amiel A; Kidron D; Weisz A; Benchetrit S; Zitman-Gal T
    Am J Reprod Immunol; 2022 Jul; ():. PubMed ID: 35810355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammasome activation in preeclampsia and intrauterine growth restriction.
    Silber M; Dekel N; Heusler I; Biron-Shental T; Amiel A; Kidron D; Weisz A; Benchetrit S; Zitman-Gal T
    Am J Reprod Immunol; 2022 Oct; 88(4):e13598. PubMed ID: 35976163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An image analysis technique for the investigation of variations in placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction.
    Daayana S; Baker P; Crocker I
    J Soc Gynecol Investig; 2004 Dec; 11(8):545-52. PubMed ID: 15582500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction.
    Lorenz-Meyer LA; Frank L; Sroka D; Busjahn A; Henrich W; Verlohren S
    Pregnancy Hypertens; 2022 Jun; 28():149-155. PubMed ID: 35453103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery.
    Sharabi-Nov A; Kumar K; Fabjan Vodušek V; Premru Sršen T; Tul N; Fabjan T; Meiri H; Nicolaides KH; Osredkar J
    Fetal Diagn Ther; 2020; 47(6):471-484. PubMed ID: 31778996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia.
    Gumus E; Atalay MA; Cetinkaya Demir B; Sahin Gunes E
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3806-11. PubMed ID: 26821682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different expression of placental pyruvate kinase in normal, preeclamptic and intrauterine growth restriction pregnancies.
    Bahr BL; Price MD; Merrill D; Mejia C; Call L; Bearss D; Arroyo J
    Placenta; 2014 Nov; 35(11):883-90. PubMed ID: 25260566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental Microarray Profiling Reveals Common mRNA and lncRNA Expression Patterns in Preeclampsia and Intrauterine Growth Restriction.
    Medina-Bastidas D; Guzmán-Huerta M; Borboa-Olivares H; Ruiz-Cruz C; Parra-Hernández S; Flores-Pliego A; Salido-Guadarrama I; Camargo-Marín L; Arambula-Meraz E; Estrada-Gutierrez G
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PP141. The lipid transporters ABCA1 and ABCG1 are differentially expressed in preeclamptic and IUGR placentas.
    Körner M; Wenger F; Nikitina L; Baumann M; Surbek D; Albrecht C
    Pregnancy Hypertens; 2012 Jul; 2(3):315-6. PubMed ID: 26105462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of monocyte subsets and polarization in preeclampsia and intrauterine fetal growth restriction.
    Alahakoon TI; Medbury H; Williams H; Fewings N; Wang XM; Lee VW
    J Obstet Gynaecol Res; 2018 Dec; 44(12):2135-2148. PubMed ID: 30058176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
    Estellés A; Gilabert J; Keeton M; Eguchi Y; Aznar J; Grancha S; Espña F; Loskutoff DJ; Schleef RR
    Blood; 1994 Jul; 84(1):143-50. PubMed ID: 8018914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
    Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
    Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial.
    García B; Llurba E; Valle L; Gómez-Roig MD; Juan M; Pérez-Matos C; Fernández M; García-Hernández JA; Alijotas-Reig J; Higueras MT; Calero I; Goya M; Pérez-Hoyos S; Carreras E; Cabero L
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):680-9. PubMed ID: 26823208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology.
    Awamleh Z; Gloor GB; Han VKM
    BMC Med Genomics; 2019 Jun; 12(1):91. PubMed ID: 31248403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction.
    Lorenzi T; Marzioni D; Giannubilo S; Quaranta A; Crescimanno C; De Luca A; Baldi A; Todros T; Tranquilli AL; Castellucci M
    Placenta; 2009 Jan; 30(1):35-40. PubMed ID: 19056122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction.
    Kwiatkowski S; Dołegowska B; Kwiatkowska E; Rzepka R; Marczuk N; Loj B; Torbè A
    J Perinat Med; 2017 Oct; 45(7):793-802. PubMed ID: 27865093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA content and methylation in fetal cord blood of pregnancies with placental insufficiency.
    Novielli C; Mandò C; Tabano S; Anelli GM; Fontana L; Antonazzo P; Miozzo M; Cetin I
    Placenta; 2017 Jul; 55():63-70. PubMed ID: 28623975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Cerebroplacental Ratio in IUGR Fetuses from Pregnancy with Preeclampsia in Prediction the Risk for Perinatal Complications.
    Novac MV; Moldoveanu A; Tudorache Ş; Oprescu ND; Miescu M; Siminel MA; Vrabie S; Novac MB; Iliescu DG
    Curr Health Sci J; 2017; 43(3):231-235. PubMed ID: 30595881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.